Clinical trial
Detoxification and Treatment of Subjects With Medication Overuse Headache
NCT00432549 · The New England Center for Headache, P.C., Other · Unknown status
Key facts
| NCT number | NCT00432549 |
|---|---|
| Title | Detoxification and Treatment of Subjects With Medication Overuse Headache |
| Official title | Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache |
| Lead sponsor | The New England Center for Headache, P.C., Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Analgesic Rebound Headache |
| Intervention type | Drug |
| Interventions | Almotriptan, Topiramate |
| Enrollment | 60 |
| Start date | Jan 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Feb 8, 2007 |
| Last update posted | Feb 8, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: